Search
Searching Content indexed under Consumer Protection by Teresa Reguly ordered by Published Date Descending.
Links to Result pages
 
1  
 
Title
Country
Organisation
Author
Date
1
Federal Court Addresses The Intention And Application Of Vanessa's Law
The Federal Court of Canada has addressed how the Protecting Canadians from Unsafe Drugs Act (Vanessa's Law) ...
Canada
27 Jul 2018
2
Look Before You Leap: Pre-Canadian Launch Regulatory Considerations For U.S. Companies
Deciding whether or not to launch a food, drug, medical device, dietary supplement or cosmetic product in Canada involves a number of considerations.
Canada
20 May 2014
3
Canada Consumer Product Safety Act Aims To Strengthen Product Safety Laws
The Canada Consumer Product Safety Act (CCPSA)1 will come into force on June 20, 2011, after receiving royal assent on December 14, 2010. It is aimed at preventing and dealing with the dangers that consumer products pose to human health or safety, as well as modernizing and strengthening product safety laws to further protect the health and safety of Canadians.
Canada
25 Jul 2011
4
Ontario Companies Doing Business With Hospitals May Become Subject To Access-To-Information Requests
Pharmaceutical and medical device companies doing business with Ontario organizations that accept public funding, including hospitals, may be affected by recent legislative amendments aimed at increasing transparency and accountability of these entities.
Canada
11 Apr 2011
5
Canadian Consumer Product Safety Act Aims To Strengthen Product Safety Laws
The Canadian Consumer Product Safety Act (CCPSA)1 will come into force on June 20, 2011. The CCPSA, introduced on June 9, 2010 as Bill C-36, received royal assent on December 14, 2010.
Canada
7 Apr 2011
6
Canada Amends Regulations On Adverse Drug Reaction Reporting
Amended regulations regarding the reporting of adverse drug reactions came into force on February 10, 2011.
Canada
15 Mar 2011
7
Ontario Government Seeks Appeal Of Pharmacies' Successful Challenge On Private Label Restrictions
The regulation of private label drug products remains in flux with the recent decision of the Ontario Superior Court of Justice (Divisional Court) and potential appeal of that decision.
Canada
28 Feb 2011
8
Canadian and U.S. Regulation of Functional Food Claims
In today’s health-conscious marketplace, functional food labelling has grown into a multibillion dollar industry.
Canada
13 Oct 2010
9
Health Canada Releases Final Guidance On Subsequent Entry Biologics
Health Canada has released the final version of its guidance document Guidance for Sponsors: Information and Submission Requirements for Subsequent Entry Biologics (SEBs) (Final Guidance), which is an update of the draft guidance released by Health Canada on January 30, 2008 and March 27, 2009 and applies to all pending and future drug submissions for SEBs in Canada.
Canada
17 Mar 2010
10
Biosimilars In Canada: New Draft Guidelines From Health Canada
Health Canada announced that it had granted marketing authorization for Omnitrope (a human growth hormone), the first subsequent entry biologic (SEB) to be approved for sale in Canada.
Canada
22 Jul 2009
11
Canada Proposes Amendments To Adverse Drug Reaction Reporting
On June 13, 2009, proposed regulations amending the Food and Drug Regulations with respect to adverse drug reaction reporting (Proposed Regulations) were published in the Canada Gazette.
Canada
19 Jun 2009
12
Canada´s Regulation Of Subsequent Entry Biologics
Health Canada has released a revised version of the draft guidance document "Information and Submission Requirements for Subsequent Entry Biologics".
Canada
8 Apr 2009
13
Draft Guidelines On Subsequent Entry Biologics
Health Canada has released a draft guidance document titled “Information and Submission Requirements for Subsequent Entry Biologics (SEBs).” The document outlines the regulatory review process that Health Canada will use for a biologic that is similar to an approved innovator biologic.
Canada
13 Mar 2008
Links to Result pages
 
1